Found: 26
Select item for more details and to access through your institution.
Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study.
- Published in:
- Muscle & Nerve, 2023, v. 68, n. 2, p. 157, doi. 10.1002/mus.27853
- By:
- Publication type:
- Article
Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies.
- Published in:
- Journal of Multidisciplinary Healthcare, 2024, v. 17, p. 4199, doi. 10.2147/JMDH.S458181
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial.
- Published in:
- Muscle & Nerve, 2021, v. 64, n. 3, p. 285, doi. 10.1002/mus.27347
- By:
- Publication type:
- Article
Combination molecular therapies for type 1 spinal muscular atrophy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Utility and practice of electrodiagnostic testing in the pediatric population: An AANEM consensus statement.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Twice‐weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy.
- Published in:
- Muscle & Nerve, 2019, v. 59, n. 6, p. 650, doi. 10.1002/mus.26441
- By:
- Publication type:
- Article
Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2144178, doi. 10.1001/jamanetworkopen.2021.44178
- By:
- Publication type:
- Article
Use of the Assessment of Caregiver Experience with Neuromuscular Disease (ACEND) in Spinal Muscular Atrophy.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 4, p. 921, doi. 10.3390/jcm13040921
- By:
- Publication type:
- Article
Restoration of Nusinersen Levels Following Treatment Interruption in People With Spinal Muscular Atrophy: Simulations Based on a Population Pharmacokinetic Model.
- Published in:
- CNS Drugs, 2022, v. 36, n. 2, p. 181, doi. 10.1007/s40263-022-00899-0
- By:
- Publication type:
- Article
Medical management of muscle weakness in Duchenne muscular dystrophy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0240687
- By:
- Publication type:
- Article
Longitudinal study of intraneural perineurioma--a benign, focal hypertrophic neuropathy of youth.
- Published in:
- Brain: A Journal of Neurology, 2009, v. 132, n. 8, p. 2265, doi. 10.1093/brain/awp169
- By:
- Publication type:
- Article
Findings from the Longitudinal CINRG Becker Natural History Study.
- Published in:
- Journal of Neuromuscular Diseases, 2024, v. 11, n. 1, p. 201, doi. 10.3233/JND-230178
- By:
- Publication type:
- Article
Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG).
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 3, p. 389, doi. 10.3233/JND-221560
- By:
- Publication type:
- Article
Longitudinal Assessment of Timed Function Tests in Ambulatory Individuals with SMA Treated with Nusinersen.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 3, p. 337, doi. 10.3233/JND-221519
- By:
- Publication type:
- Article
INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy.
- Published in:
- Journal of Neuromuscular Diseases, 2022, v. 9, n. 4, p. 503, doi. 10.3233/JND-210781
- By:
- Publication type:
- Article
Localized Aquadynia Responsive to Clonidine in a 13-Year-Old Girl.
- Published in:
- Pediatric Dermatology, 2010, v. 27, n. 6, p. 646, doi. 10.1111/j.1525-1470.2010.01132.x
- By:
- Publication type:
- Article
Updates in the Use of Vamorolone and Steroids in the Treatment of Duchenne Muscular Dystrophy.
- Published in:
- touchREVIEWS in Neurology, 2023, v. 19, n. 2, p. 1, doi. 10.17925/USN.2023.19.2.5
- By:
- Publication type:
- Article
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Unusual Case of Relapsing and Remitting Rash With Progressive Motor Sensory Neuropathy and Spinal Cord Atrophy.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Management of Pediatric Central Nervous System Demyelinating Disorders: Consensus of United States Neurologists.
- Published in:
- Journal of Child Neurology, 2011, v. 26, n. 6, p. 675, doi. 10.1177/0883073810395141
- By:
- Publication type:
- Article
Orthostatic Heart Rate and Blood Pressure in Adolescents: Reference Ranges.
- Published in:
- Journal of Child Neurology, 2010, v. 25, n. 10, p. 1210, doi. 10.1177/0883073809359539
- By:
- Publication type:
- Article
Review Article: Nerve Conduction Studies in Infants and Children.
- Published in:
- Journal of Child Neurology, 1986, v. 1, n. 1, p. 19, doi. 10.1177/088307388600100103
- By:
- Publication type:
- Article
Moderate exercise improves function and increases adiponectin in the mdx mouse model of muscular dystrophy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-42203-z
- By:
- Publication type:
- Article
The electrophysiologic profile of Dejerine-Sottas disease (HMSN III).
- Published in:
- Muscle & Nerve, 1990, v. 13, n. 7, p. 586, doi. 10.1002/mus.880130705
- By:
- Publication type:
- Article